Alys was honored to be represented at this year's DDDS by Lars French : thank you for presenting our lead assets with clarity and enthusiasm!
Professor & Chairman, Dept. Dermatology, Ludwig-Maximilian University Hospital, Munich, Germany
Thanks to the organizers of the 8th Annual Dermatology Drug Development Summit in Boston for inviting me to speak in the session devoted to "Optimizing the delivery of dermatological agents to increase targeting specificity in inflammatory environments". Was a pleasure to highlight unmet needs in dermatology and innovative drug candidates in the pipeline of #AlysPharmaceuticals (www.alyspharma.com), including a unique #bispecific mAb that selectively antagonizes mast-cell c-Kit planned for clinical trials in chronic spontaneous urticaria, and a unique #siRNA platform technology with #Jak1 siRNA for transepidermal delivery and skin selective Jak1 silencing as its lead planned for clinical trials in atopic dermatitis. #ThibaudPortal, #JohnHarris, #BrianKim, #CraigMello, #CarineBlanchard, #ClaireBouixPeter, #EmmanuelVial, #JonnyFinlay, #OrlaCunningham